Maze Therapeutics teams with Zifo to enhance precision medicine data tools
Maze Therapeutics will use Zifo's AI-enabled informatics to manage UK Biobank and All of Us data, aiming to accelerate genetically informed target discovery and validation for kidney, metabolic and other therapeutic programmes.
Why it mattersIntegrating UK Biobank and All of Us with Zifo's AI enables faster target validation, informing go/no‑go decisions.